Wolf succeeds Fabrice Romano, founder of the company, who remains a member of the board.

Dietrich Wolf joins the company with the view to establishing High Intensity Focused Ultrasound (HIFU) as a recognized future option in glaucoma care. The EyeOP1 device has been launched to select centers in France and neighboring countries for highly advanced refractory glaucoma. The next steps will include further roll out in Europe and preparation for overseas markets. EyeTechCare also plan to research the indication for less advanced glaucoma cases, to further increase the number of patients eligible for this new therapy.